COMP <GO>
IMUX vs VTVT // ALTMAN Z-SCORE & DEBT/EQUITY
Immunic Inc. (NASDAQ) VS. vTv Therapeutics Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: IMUX 2
— VTVT 0
■ METRIC PARITY
LAST: $7.51 (-3.66%) • MKT CAP: $106.4M
balance-sheet
—
LAST: $25.17 (-4.59%) • MKT CAP: $104.3M
balance-sheet
0.20
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMUX VS. VTVT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMUX | VTVT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -24.21% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 2/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 32.8 | +7.42 | IMUX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $106.4M | $104.3M | $2.1M | IMUX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMUX REV | VTVT REV | IMUX GROSS % | VTVT GROSS % | IMUX FCF | VTVT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$86.0M | -$25.3M |
| FY 2024 | $0 | $1.0M | — | — | -$85.0M | -$25.3M |
| FY 2023 | $0 | $0 | — | — | -$70.8M | -$19.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMUX // BETA —
VTVT // BETA —